LeMaitre Vascular: Business Model, SWOT Analysis, and Competitors 2026

LeMaitre Vascular, Inc. stands as a leading company in Healthcare. Generating $249.60 million in annual revenue (growing 15.7% year-over-year) and carrying a market capitalization of $2.41 billion, the company has cemented its position as a foundational player in the global Medical Instruments & Supplies landscape. Under the leadership of its leadership team, LeMaitre Vascular, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines LeMaitre Vascular, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating LeMaitre Vascular, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define LeMaitre Vascular, Inc.'s position in the Medical Instruments & Supplies market today.

What You Will Learn

1. How LeMaitre Vascular, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering LeMaitre Vascular, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who LeMaitre Vascular, Inc.'s main competitors are and how the company compares on key financial metrics
4. LeMaitre Vascular, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. LeMaitre Vascular, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $249.60 million annual revenue (TTM), +15.7% YoY
• Market Cap: $2.41 billion — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 70.4%, operating margin 21.8%, net margin 23.1%
• Free Cash Flow: $47.35 million
• Return on Equity: 15.8% — strong
• Employees: 646 worldwide

Who Owns LeMaitre Vascular, Inc.?

LeMaitre Vascular, Inc. is publicly traded on the NGM under the ticker symbol LMAT. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of LeMaitre Vascular, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

LeMaitre Vascular, Inc. has approximately 0.02 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $106.15 per share as of early 2026.

LeMaitre Vascular, Inc.'s Mission Statement

LeMaitre Vascular, Inc.'s strategic mission is aligned with its core business activities in the Medical Instruments & Supplies sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — LeMaitre Vascular, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For LeMaitre Vascular, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, LeMaitre Vascular, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does LeMaitre Vascular, Inc. Make Money?

As of 2026, LeMaitre Vascular, Inc. generates $249.60 million in annual revenue (growing 15.7% year-over-year), with a 70.4% gross margin and 21.8% operating margin. Market capitalization stands at $2.41 billion. Here is how the company generates its revenue:

Lemaitre Vascular ensures product quality through strict adherence to regulatory standards and a strong commitment to research and development.

What is the significance of R&D for Lemaitre Vascular?

Research and development is crucial for Lemaitre Vascular as it drives innovation, enhances product offerings, and helps the company meet evolving healthcare needs.

Is Lemaitre Vascular publicly traded?

Yes, Lemaitre Vascular Inc. is publicly traded on the NASDAQ under the ticker symbol "LMAT".

By understanding Lemaitre Vascular's business model, SWOT analysis, and competitive landscape, stakeholders can better appreciate the company's position and potential growth trajectory in the evolving healthcare market.

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review LeMaitre Vascular, Inc.'s latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

LeMaitre Vascular, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how LeMaitre Vascular, Inc. creates, delivers, and captures value.

Key Partners: LeMaitre Vascular, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Medical Instruments & Supplies sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: LeMaitre Vascular, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: LeMaitre Vascular, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (646 employees), proprietary technology, and financial resources ($359.12M in cash).

Value Propositions: LeMaitre Vascular, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Medical Instruments & Supplies market.

Customer Relationships: LeMaitre Vascular, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: LeMaitre Vascular, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: LeMaitre Vascular, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: LeMaitre Vascular, Inc.'s major costs include cost of goods sold (29.6% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 78.2% of revenue.

Revenue Streams: LeMaitre Vascular, Inc. generates revenue through its core product and service offerings.

LeMaitre Vascular, Inc. Competitors

LeMaitre Vascular, Inc. competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Medical Instruments & Supplies segment of the Healthcare sector.

LeMaitre Vascular, Inc. SWOT Analysis

A SWOT analysis examines LeMaitre Vascular, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: LeMaitre Vascular, Inc.'s gross margin of 70.4% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 21.8% demonstrates disciplined cost management even at scale.
• Revenue Growth: Revenue grew 15.7% year-over-year to $249.60M, indicating strong demand for LeMaitre Vascular, Inc.'s products and services and outperformance relative to many industry peers.
• Capital Efficiency: A return on equity of 15.8% demonstrates that LeMaitre Vascular, Inc. generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• Competitive Scale Pressure: In the Medical Instruments & Supplies sector, larger competitors with greater economies of scale can exert pricing pressure and outspend LeMaitre Vascular, Inc. on marketing, R&D, and distribution — limiting the company's ability to defend market share in a price-sensitive environment.
• Market Concentration Risk: Revenue concentration in core markets or customer segments creates vulnerability to localized downturns, regulatory changes, or shifts in customer preferences. Diversification remains an ongoing strategic challenge.

Opportunities

• Total Addressable Market: LeMaitre Vascular, Inc. operates in the Medical Instruments & Supplies segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for LeMaitre Vascular, Inc.'s products and services.
• Earnings Momentum: Earnings growth of 41.4% YoY demonstrates LeMaitre Vascular, Inc.'s ability to convert revenue growth into shareholder value. Analysts project continued earnings expansion driven by operating leverage as fixed costs are amortized across a growing revenue base.
• Strategic Acquisitions: With $359.12M in cash and strong free cash flow generation, LeMaitre Vascular, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. LeMaitre Vascular, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on LeMaitre Vascular, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

LeMaitre Vascular, Inc. enters 2026 as a leading company in Healthcare, backed by $249.60 million in annual revenue and a 23.1% net profit margin. The company's 70.4% gross margins and $47.35 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in LeMaitre Vascular, Inc.'s core markets.

For investors, LeMaitre Vascular, Inc.'s 45.8x trailing P/E and 33.6x forward P/E reflect the market's expectations for continued strong growth. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – LeMaitre Vascular, SEC EDGAR – LeMaitre Vascular Filings, and LeMaitre Vascular's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. What does Lemaitre Vascular Inc. specialize in?

LeMaitre Vascular, Inc. generated $249.60 million in annual revenue with a 23.1% net profit margin as of the latest reporting period. The company operates in the Medical Instruments & Supplies sector. For the most current information, consult LeMaitre Vascular, Inc.'s investor relations page.

2. When was Lemaitre Vascular Inc. founded?

LeMaitre Vascular, Inc. generated $249.60 million in annual revenue with a 23.1% net profit margin as of the latest reporting period. The company operates in the Medical Instruments & Supplies sector. For the most current information, consult LeMaitre Vascular, Inc.'s investor relations page.

3. What markets does Lemaitre Vascular serve?

LeMaitre Vascular, Inc. generated $249.60 million in annual revenue with a 23.1% net profit margin as of the latest reporting period. The company operates in the Medical Instruments & Supplies sector. For the most current information, consult LeMaitre Vascular, Inc.'s investor relations page.

4. Who are Lemaitre Vascular's main competitors?

LeMaitre Vascular, Inc. competes in the Medical Instruments & Supplies segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Medical Instruments & Supplies center on product differentiation, pricing strategy, and distribution scale.

5. What are some opportunities for Lemaitre Vascular in the future?

LeMaitre Vascular, Inc.'s key growth opportunities include: LeMaitre Vascular, Inc. operates in the Medical Instruments & Supplies segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gai Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for LeMaitr Earnings growth of 41.4% YoY demonstrates LeMaitre Vascular, Inc.'s ability to convert revenue growth into shareholder value. Analysts project continued earnings expansion driven by operating leverage

6. How does Lemaitre Vascular ensure product quality?

LeMaitre Vascular, Inc. generates $249.60 million in annual revenue (TTM) with a 70.4% gross margin, growing 15.7% year-over-year. The company's revenue model is described in detail in the business model section above.

7. What is the significance of R&D for Lemaitre Vascular?

LeMaitre Vascular, Inc. generated $249.60 million in annual revenue with a 23.1% net profit margin as of the latest reporting period. The company operates in the Medical Instruments & Supplies sector. For the most current information, consult LeMaitre Vascular, Inc.'s investor relations page.

8. Is Lemaitre Vascular publicly traded?

LeMaitre Vascular, Inc. generated $249.60 million in annual revenue with a 23.1% net profit margin as of the latest reporting period. The company operates in the Medical Instruments & Supplies sector. For the most current information, consult LeMaitre Vascular, Inc.'s investor relations page.